Flexion Therapeutics

YTD

ALL

Why Robinhood?

You can watch FLXN and buy or sell other stocks, ETFs, and their options commission-free!

About FLXN

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis.

CEO

Ronald Ellis

CEORonald Ellis

Employees

—

Employees—

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2007

Founded2007

Employees

—

Employees—

FLXN Key Statistics

Market cap

458.93M

Market cap458.93M

Price-Earnings ratio

-4.76

Price-Earnings ratio-4.76

Dividend yield

—

Dividend yield—

Average volume

3.03M

Average volume3.03M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$13.66

52 Week high$13.66

52 Week low

$4.30

52 Week low$4.30

People also own

Based on the portfolios of people who own FLXN. This list is generated using Robinhood data, and it’s not a recommendation.